Dialysis Modality Choice for the Elderly Patient with End-Stage Renal Disease

2012 ◽  
pp. 83-88 ◽  
Author(s):  
Mitchell H. Rosner ◽  
Claudio Ronco
Keyword(s):  
Elderly Patient ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
The Elderly ◽  
Dialysis Modality ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals End-Stage Renal Disease Affect Mortality of Hip Fractures Treated with Hemiarthroplasty in the Elderly

2018 ◽  
Author(s):  
Mesut Tahta ◽  
Eyup Cagatay Zengin ◽  
Cem Ozcan ◽  
Tahir Ozturk ◽  
Tugrul Bulut ◽  
...  
Keyword(s):  
Renal Disease ◽  
Hip Fractures ◽  
End Stage Renal Disease ◽  
The Elderly ◽  
Stage Renal Disease ◽  
End Stage

Racial Differences in Choice of Dialysis Modality for Children With End-stage Renal Disease

PEDIATRICS ◽  
1997 ◽  
Vol 99 (4) ◽  
pp. e6-e6 ◽  
Author(s):  
S. L. Furth ◽  
N. R. Powe ◽  
W. Hwang ◽  
A. M. Neu ◽  
B. A. Fivush
Keyword(s):  
Renal Disease ◽  
Racial Differences ◽  
End Stage Renal Disease ◽  
Dialysis Modality ◽  
Stage Renal Disease ◽  
End Stage

End-Stage Renal Disease Patients with Low Serum Albumin: Is Peritoneal Dialysis an Option?

2019 ◽  
Vol 39 (6) ◽  
pp. 562-567 ◽  
Author(s):  
Tripti Singh ◽  
Brad C. Astor ◽  
Sana Waheed
Keyword(s):  
Peritoneal Dialysis ◽  
Renal Disease ◽  
Serum Albumin ◽  
End Stage Renal Disease ◽  
Chronic Dialysis ◽  
Lower Mortality ◽  
Dialysis Modality ◽  
Stage Renal Disease ◽  
End Stage ◽  
Low Serum

Introduction Low serum albumin is associated with high mortality in patients with end-stage renal disease (ESRD) on chronic dialysis. Clinicians are reluctant to offer peritoneal dialysis (PD) as an option for dialysis for patients with low serum albumin due to concerns of loss of albumin with PD, but evidence supporting differences in outcomes is limited. We evaluated mortality based on dialysis modality in patients with very low serum albumin (< 2.5 g/dL). Methods We analyzed United States Renal Data System (USRDS) data from 2010 to 2015 to assess mortality by modality adjusted for age, sex, race, employment, number of comorbidities, and year of dialysis initiation. Results Low serum albumin (< 2.5 g/dL) was present in 78,625 (19.9%) of 395,656 patients with ESRD on chronic dialysis. Patients with low serum albumin were less likely to use PD as their first modality than those with higher albumin (3.1% vs 10.9%; p < 0.001). Use of PD was associated with lower mortality compared with hemodialysis (HD) (hazard ratio [HR] = 0.88, 95% confidence interval [CI] 0.81 – 0.95, p < 0.05) in patients with low serum albumin. This difference was more pronounced in patients who had glomerulonephritis (HR = 0.72) or hypertension (HR = 0.81) than in those with end-stage renal disease (ESRD) due to diabetes mellitus or other causes. Conclusion Peritoneal dialysis is less likely to be the first dialysis modality in patients with low serum albumin requiring dialysis. However, PD is associated with lower mortality than HD in patients with low serum albumin on dialysis. We recommend advocating the use of PD in patients with low serum albumin.

scholarly journals Dialysis modality and 2-year outcomes in patients with ischemic cardiomyopathy and end-stage renal disease

2014 ◽  
Vol 176 (3) ◽  
pp. 1097-1099 ◽  
Author(s):  
Vinay Bahadur Panday ◽  
Zi-Ping Tong ◽  
Perryn L. Ng ◽  
Evan J. Lee ◽  
Titus Lau ◽  
...  
Keyword(s):  
Renal Disease ◽  
End Stage Renal Disease ◽  
Ischemic Cardiomyopathy ◽  
Dialysis Modality ◽  
Stage Renal Disease ◽  
End Stage

The impact of dialysis modality on arterial stiffness in patients with end-stage renal disease

Renal Failure ◽  
2010 ◽  
Vol 32 (8) ◽  
pp. 947-953 ◽  
Author(s):  
Jae Hyun Chang ◽  
Se-Jung Yoon ◽  
Seung Hyeok Han ◽  
Sug Kyun Shin ◽  
Dong Woon Jeon ◽  
...  
Keyword(s):  
Arterial Stiffness ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Dialysis Modality ◽  
Stage Renal Disease ◽  
End Stage ◽  
The Impact
Sign in / Sign up

Export Citation Format

Share Document